Effect on lipids and reverse cholesterol transport of switching to unboosted atazanavir vs remaining on ritonavir-boosted atazanavir in regimens with a tenofovir backboneM. Harris,R. Saeedi, B. Ganase,M. Yousefi,J. Dubland,G. A. Francis,S. Guillemi,M. Hull,J. S. G. MontanerANTIVIRAL THERAPY（2014）引用 1|浏览6暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
